Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)
Clinical trial NCT03587376 · COMPLETED
Trial details
- NCT number
- NCT03587376
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2018-08-23
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.